Tobira Therapeutics, Inc.
DelistedCIK 1311596fmd_1R5C1DXBP9XNAA85K05AEEXCTKManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2012 to Jun 30, 2016, 16 periods
Latest annual · FY2015
Millions- Operating income
- (53)
- Net income
- (50)
- Free cash flow
- (31)
Latest quarter · Q2 FY2016
Millions- Operating income
- (13)
- Net income
- (13)
Tobira Therapeutics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2015 | FY2014 | Change | Source |
|---|---|---|---|---|
| Operating income | -$52.9 million | -$20 million | 10-K 2016-03-03 · proof | |
| Net income | -$49.6 million | -$24.1 million | 10-K 2016-03-03 · proof | |
| Cash from operating activities | -$31.3 million | -$18.7 million | 10-K 2016-03-03 · proof | |
| Free cash flow | -$31.3 million | -$18.8 million | 10-K 2016-03-03 · proof | |
| Total assets | $65.4 million | $8.3 million | +683.7% | 10-Q 2016-05-09 · proof |
| Total liabilities | $22.6 million | $55.7 million | -59.4% | 10-Q 2016-05-09 · proof |
| Cash and cash equivalents | $62.4 million | $6.2 million | +910.5% | 10-K 2016-03-03 · proof |
- What was Tobira Therapeutics, Inc.'s operating income in fiscal 2015?
- Tobira Therapeutics, Inc. reported operating income of -$52.9 million for fiscal 2015 (the year ended Dec 31, 2015), against -$20 million the year before. Source: the 10-K filed with the SEC on Mar 3, 2016. SEC
- What was Tobira Therapeutics, Inc.'s net income in fiscal 2015?
- Tobira Therapeutics, Inc. reported net income of -$49.6 million for fiscal 2015 (the year ended Dec 31, 2015), against -$24.1 million the year before. Source: the 10-K filed with the SEC on Mar 3, 2016. SEC
- What was Tobira Therapeutics, Inc.'s cash from operating activities in fiscal 2015?
- Tobira Therapeutics, Inc. reported cash from operating activities of -$31.3 million for fiscal 2015 (the year ended Dec 31, 2015), against -$18.7 million the year before. Source: the 10-K filed with the SEC on Mar 3, 2016. SEC
- What was Tobira Therapeutics, Inc.'s free cash flow in fiscal 2015?
- Tobira Therapeutics, Inc. reported free cash flow of -$31.3 million for fiscal 2015 (the year ended Dec 31, 2015), against -$18.8 million the year before. Source: the 10-K filed with the SEC on Mar 3, 2016. SEC
- What are Tobira Therapeutics, Inc.'s total assets?
- As of Dec 31, 2015, Tobira Therapeutics, Inc. reported total assets of $65.4 million, against $8.3 million a year earlier (+683.7%). Source: the 10-Q filed with the SEC on May 9, 2016 (restated). SEC
- What are Tobira Therapeutics, Inc.'s total liabilities?
- As of Dec 31, 2015, Tobira Therapeutics, Inc. reported total liabilities of $22.6 million, against $55.7 million a year earlier (-59.4%). Source: the 10-Q filed with the SEC on May 9, 2016 (restated). SEC
- What are Tobira Therapeutics, Inc.'s cash and cash equivalents?
- As of Dec 31, 2015, Tobira Therapeutics, Inc. reported cash and cash equivalents of $62.4 million, against $6.2 million a year earlier (+910.5%). Source: the 10-K filed with the SEC on Mar 3, 2016. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1311596&period_type=annual&limit=5"Information only, not investment advice.